Global Blood Culture Tests Market to Exhibit 7.25% CAGR 2016-2020

Published Date : Sep 26, 2016

ALBANY, NY, Sep 26, 2016: A recent market intelligence report added to presents a sweeping account of the present state of the global blood culture tests market and forecasts the state of the market through the period 2016-2020. The report, titled “Global Blood Culture Tests Market 2016-2020,” states that the market will exhibit a healthy 7.25% CAGR over the said period.

The market will be chiefly driven by the rising rate of outsourcing of blood samples to private reference laboratories. Reference labs are testing service providers that assist end-use segments such as clinical trials, hospitals, genomics, corporate wellness programs, insurance, sample tracking, molecular diagnostics carry out a variety of blood culture tests. A rising number of public hospitals are outsourcing testing services to independent labs owing to the benefits offered such as productivity gains, lower turnaround time, and cost savings. The trend is expected to propel the global blood culture tests market in the next few years.

The rising demand for quick diagnostics tests is also a crucial factor that is expected impelling the overall growth of the market over the forecast period. As rapid diagnostics tests enable the speedy diagnosis of pathogens in the blood, they aid in the effective and timely targeting of antimicrobial therapy across health care centers. Moreover, many advanced rapid diagnostic tests are also more accurate than conventional tests and offer cost effective diagnosis.

The report segments the global blood culture tests market on the basis of technology and geography. On the basis of technology, the market is segmented into conventional or manual blood culture tests and automated blood culture tests. Of these, the segment of conventional blood culture tests accounted for a dominant share of 62% in the market’s overall revenues in 2015.

For Sample Copy, click here:

Conventional blood culture techniques are mostly technically simple but are labor intensive owing to the need for visual inspection of the test sample. However, these techniques are prone to contamination and low sensitivity as compared to automated blood culture tests. As a result, the demand for automated blood culture tests is expected to significantly rise in the next few years.

Geographically, Americas dominated the global blood culture tests market in 2015, holding a 48% share. Leading position of the region in the global blood culture tests market is owing to the high awareness about infections that are transmitted via transfusion. The rising prevalence of a number of chronic diseases that require blood transfusion has also had a significant positive impact on the overall development of the blood culture tests market in the region lately.

The market features intense competitiveness owing to the presence of a large number of global and domestic players. Some of the key vendors operating in the market are Roche Diagnostics, bioMérieux, Cepheid, ThermoFisher Scientific, AdvanDX, AB Sciex, Nanosphere, Beckman Coulter, Eurogentec, Bruker, IRIDICA, and Dade Behring.

To order report Call Toll Free: 866-997-4948 or send an email on